Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.15 is in line with its 5-year average of 9.16, near the low end of its 5-year range (6.50–15.77).
As of the fiscal period ended Tuesday, June 30, 2026. 3.84% above its 12-month average of 8.81.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.15.
CURRENT RATIO
9.15
CURRENT RATIO AVG TTM
8.81
CURRENT RATIO AVG 3Y
9.15
CURRENT RATIO AVG 5Y
9.16
CURRENT RATIO AVG 10Y
9.51
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.84%
CURRENT VS 3Y AVG
-0.07%
CURRENT VS 5Y AVG
-0.14%
CURRENT VS 10Y AVG
-3.77%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+143.27%
vs the sector median at left
Market Cap
$870.81M
Current Ratio
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$857.16M
Current Ratio
1.39
TTM Avg
1.36
3Y Avg
1.46
5Y Avg
2.28
Market Cap
$853.13M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
Market Cap
$852.35M
Current Ratio
3.05
TTM Avg
43.83
3Y Avg
35.58
5Y Avg
35.58
Market Cap
$884.97M
Current Ratio
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$887.99M
Current Ratio
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SI-BONE, Inc. (SIBN) | $867.03M | 9.15 | 8.81 | 9.15 | 9.16 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | 11.36 | 7.20 | 7.20 | 7.20 |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | 1.39 | 1.36 | 1.46 | 2.28 |
| Alumis Inc. (ALMS)vs › | $855.38M | 6.74 | 5.17 | 5.15 | 5.15 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.95 | 2.27 | 2.05 | 2.13 |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | 3.05 | 43.83 | 35.58 | 35.58 |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 81.42 | 11.94 | 8.59 | 10.34 |
| Bioventus Inc. (BVS)vs › | $887.50M | 1.69 | 1.50 | 1.36 | 1.44 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 16.16 | 3.88 | 3.97 | 4.50 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | 4.92 | 7.19 | 6.36 | 8.34 |
Current Ratio
9.15
Quick Ratio
7.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.15 |
| 2026-03-31 | 9.99 |
| 2025-12-31 | 8.55 |
| 2025-09-30 | 7.97 |
| 2025-06-30 | 8.38 |
| 2025-03-31 | 8.53 |
| 2024-12-31 | 7.66 |
| 2024-09-30 | 8.25 |
| 2024-06-30 | 9.17 |
| 2024-03-31 | 9.76 |
| 2023-12-31 | 9.01 |
| 2023-09-30 | 10.89 |
| 2023-06-30 | 11.68 |
| 2023-03-31 | 7.72 |
| 2022-12-31 | 6.50 |
| 2022-09-30 | 7.50 |
| 2022-06-30 | 8.90 |
| 2022-03-31 | 10.44 |
| 2021-12-31 | 10.41 |
| 2021-09-30 | 12.75 |
| 2021-06-30 | 15.77 |
| 2021-03-31 | 15.18 |
| 2020-12-31 | 16.20 |
| 2020-09-30 | 12.65 |
| 2020-06-30 | 13.18 |
| 2020-03-31 | 7.87 |
| 2019-12-31 | 5.94 |
| 2019-09-30 | 8.78 |
| 2019-06-30 | 12.00 |
| 2019-03-31 | 13.06 |
| 2018-12-31 | 15.11 |
| 2018-09-30 | 2.78 |
| 2018-06-30 | 3.75 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 4.46 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 2.77 |
| 2016-03-31 | 0.00 |
| 2015-03-31 | 2.87 |
| 2014-12-31 | 3.74 |
| 2014-03-31 | 0.00 |
